Otros idiomas CervoMed Inc.

Acciones

CRVO

US15713L1098

Diferido Nasdaq Otros sitios de cotización 15:37:21 24/06/2024			Varia. Cinco días.	Varia. 1 de enero.
19,95 ^USD	+0,15 %		+6,97 %	+161,47 %

11/06	CervoMed Inc. Anuncia la finalización de la inscripción en el ensayo clínico de fase 2b RewinD-LB de neflamapimod para el tratamiento de pacientes con demencia con cuerpos de Lewy	CI
29/05	CERVOMED INC. : JonesTrading Institutional Services Eleva su recomendación a compra	ZM

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

CervoMed Announces Addition to Russell 2000® and Russell 3000® Indexes	14:01
CervoMed : Corporate Presentation June 2024	11/06
CervoMed Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy Bodies	11/06
CervoMed Inc. Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy Bodies	11/06
CervoMed Names William Elder CFO	20/05
CervoMed to Appoint William Elder as Chief Financial Officer	20/05
CervoMed Inc. Announces Chief Financial Officer Changes	20/05
Earnings Flash (CRVO) CERVOMED Posts Q1 Revenue $2.3M	15/05
CervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates	15/05
CervoMed Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
CervoMed : Nominating and Corporate Governance Committee Charter	06/05
CervoMed : Corporate Presentation April 2024	22/04
CervoMed : Corporate Presentation April 2024	03/04
CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates	01/04
CervoMed Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
CervoMed to Participate in Upcoming Investor Conferences	28/03
CervoMed Prices $50 Million Equity Sale to Private Investors	28/03
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors	28/03
CervoMed Inc. announced that it expects to receive $49.999967 million in funding	28/03
CervoMed : Shareholder Meeting - Form 8-K	18/03

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas CervoMed Inc.

Acciones

CRVO

US15713L1098

Otros idiomas

Filtros